Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
Samrawit Terefe, Pediatrician at Motite Fura Hospital, shared a post on LinkedIn:
“A notification from a Telegram group for O-negative blood donors in Hawassa popped up on my phone.
A woman with severe anemia urgently needed more than two units of blood to undergo a surgery.
Her blood type: O-negative.
At that time, the blood bank – serving a catchment population of more than 10 million – had only one unit available.
Despite ongoing campaigns and tirelesseffortof the blood banks, blood shortages remain a constant challenge.
And moments like this highlight a deeper issue: our culture of voluntary blood donation is still far from where it needs to be.
The O-negative Telegram group was created out of necessity.
O-negative blood can be given to anyone, yet it can only be received from O-negative donors – making it incredibly scarce.
What’s striking, and at times disheartening, is that even individuals who have previously benefited from blood donations – either personally or through loved ones – are sometimes reluctant to give back or even join such initiatives.
And yet, there is hope.
Thanks to the swift and selfless response of donors in these groups – both in Addis Ababa and Hawassa – many lives have been saved.
This patient, too, underwent surgery after my self and another group member donated and she is now stable.
This experience leaves me with an important question:
How can we strengthen a culture of regular, voluntary blood donation in our communities?
One practical step could be scaling similar donor networks across cities.
These small, coordinated efforts are already making a life-saving difference.
Because in the end, blood is not manufactured – it is given.
Let us give blood
Let us save lives!!!”
Stay updated with Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications